| Date | Title | Description |
| 31.07.2026 | Deep Tech Reshapes Venture Capital: AI Infrastructure Commands Billions | Venture capital rapidly reorients. Major investments now target foundational infrastructure for the booming AI economy. This pivotal shift prioritizes hardware-heavy deep tech. Key sectors include advanced space technology, innovative clean... |
| 30.07.2026 | Venture Capital & Startup Funding Roundup, July 30, 2026: Bessemer Venture Partners, G2 Venture Partners, ICONIQ Growth, Kleiner Perkins, Lightspeed & More | Tech investors are doubling down on the infrastructure underpinning today’s AI boom – from satellites in orbit to power-hungry data centers on Earth. The day’s largest deals span space tech, clean energy and AI-infused enterprise platforms,... |
| 30.10.2025 | Resilience: $825 Million In Long-Term Financing Secured From Oak Hill Advisors | Resilience, a technology-driven biomanufacturing company focused on broadening access to complex medicines, announced it has secured long-term debt financing of up to $825 million from Oak Hill Advisors (OHA). The funding would strengthen t... |
| 10.09.2025 | Ridge Biotechnologies Raises $25M in Seed Financing | Ridge Biotechnologies, a Palo Alto, CA-based company providing an enzyme and targeted drug design to improve the precision medicines, raised $25M in Seed funding.
The round was led by Sutter Hill Ventures (SHV) with participation from Overl... |
| 27.08.2025 | Better Meat Co. Fuels Mycoprotein Future with $31M, Adds Biotech Icon | The Better Meat Co. (BMC) successfully raised $31 million in Series A funding. This capital fuels the commercial scaling of its Rhiza™ mycoprotein. Rhiza™, a revolutionary fermentation-derived ingredient, significantly improves traditional ... |
| 26.08.2025 | Biotech Leader Dr. Pamela Marrone Joins Better Meat Co. Board of Directors | The Better Meat Co. (BMC), a company focused on fermentation-derived ingredients for the food industry, has announced the addition of Dr. Pamela Marrone to its Board of Directors. Dr. Marrone, based in Davis, California, brings extensive ex... |
| 27.05.2025 | Is Third-Party Risk Now the Weakest Link in Cybersecurity? | From hyper-scalers to startups, third-party suppliers are now integral to the global business ecosystem – but as they multiply and entrench, the inevitable software sprawl expands the attack surface organisations must defend.
Third party ri... |
| 29.04.2025 | JPMorgan CISO Calls for ‘Urgent’ Overhaul of Third-party Vendor Security | The chief information and security officer (CISO) of JPMorgan Chase, Patrick Opet is calling out third-party vendors to boost their security practices following major service disruptions across financial services.
JPMorgan Chase understands... |
| 14.03.2025 | QBE Ventures invests in Converge | QBE Ventures QBE Ventures
Founded: 2017
Headquarters: Sydney, New South Wales, Australia
See full company profile "> has invested in Converge Insurance Converge Insurance
Founded: 2021
Headquarters: New York, New York, United States... |
| 27.02.2025 | Third-party risk is biggest cybersecurity blind spot | Third-party risk has emerged as a dominant driver of cyber insurance claims and material losses in 2024, according to new data from leading cyber risk solutions company Resilience.
Cyber insurance claims data shows that third-party risk, in... |
| 17.02.2025 | 47% of Firms Suffered From Vendor and Supply-chain Attacks in 2024 | Security issues – leaks, breaches, hacks – involving third-party vendors continue to terrorise enterprises, research from cybersecurity firm Resilience shows.
The firm found that nearly half (47%) of organisations suffered an disruptive out... |
| 02.10.2024 | Formality raises €8M in first round to simplify contract management | Formality, a platform dedicated to intelligent contract management for clients and suppliers, has announced today that it has raised €8 million.
This first round was carried out with VC funds Partech and Serena, two major players in support... |
| 23.05.2024 | Resilience raises $25M to expand remote oncology patient monitoring | Healthtech company Resilience, already deployed in more than 90 medical centres representing over 10,000 patients, has raised $25 million.
Remote has developed a remote patient monitoring platform—classified as a class IIa medical device—al... |
| 20.02.2024 | Resilience to expand capabilities at RTP facility | National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, announced the expansion of the company’s clinical and commercial drug product manufacturing capabilit... |
| 19.10.2023 | How To Scale Culture As A Rapid-Growth Start-Up | Strandlund and her team provide tools, e-learning, and other ways to make learning come to life on ... [+] the job.getty |
| 16.02.2023 | Resilience Signs Multi-Year Strategic Biomanufacturing Partnership with Leading Pharmaceutical Company | National Resilience, (Resilience), a technology-focused manufacturing company dedicated to broadening access to complex medicines, announced a 10-year biomanufacturing partnership with a leading pharmaceutical company for its portfolio of s... |
| 11.01.2023 |
National Resilience Gets Investments From Mubadala
| San Diego-based National Resilience, a provider of biopharmaceuticals manufacturing, said on Tuesday that it has received an equity investment from adala Investment Company PJSC (Mubadala), one of Abu Dhabi's sovereign investment funds. Fin... |
| 04.07.2022 | Resilience Grabs $1.25B in Funding | The Resilience facility in the Allston neighborhood of Boston. Photo courtesy National Resilience, Inc. National Resilience, Inc. (Resilience) is on a mission to reinvent biomanufacturing – a well-funded mission.
Last month, the company ann... |
| 06.06.2022 | ARCH-backed Resilience nabs its latest financing round, putting together a massive $625M Series D | - |
| 06.06.2022 | National Resilience Announces $625M Series D |
SAN DIEGO, CA, National Resilience, a technology-focused biomanufacturing company, has raised $625 million in a Series D financing.
>> Click here for more funding data on National Resilience
>> To export National Resilience ... |
| 06.06.2022 | Resilience Raises $625M in Series D Financing | National Resilience, Inc., a San Diego, CA-based technology-focused biomanufacturing company dedicated to broadening access to complex medicines, raised $625m in Series D financing.
The latest up-round financing – in addition to a previousl... |
| 21.04.2022 | The Top 40 Investors In Industrial Tech: How Investments In Transformative Solutions Using AI, Cloud, And Edge Act Like Probiotics For Manufacturing | Traditionally, few venture capitalists would touch industrial startup companies. Time cycles were too long and clunky hardware complicated things. However, deep digitalization is taking hold, the expectations are that the industrial sector ... |
| 19.05.2021 |
Resilience Gets $164M From Government Of Canada
| San Diego-based National Resilience, a new manufacturing and technology company focused on making sure countries can manufacture their own vaccines and other threapeutics, says it has received $163.8M in a funding from the Government of Can... |
| 01.12.2020 | Resilience – Raging at the Pandemic, a VC raises $800M for a Company That Aims to Transform Biotech Manufacturing | - |
| 23.11.2020 | RESILIENCE Launches to Change the Future of Medicine through Manufacturing Innovation | SAN DIEGO and BOSTON, Nov. 23, 2020 /PRNewswire/ -- RESILIENCE (National Resilience, Inc.), a new company building the world's most advanced biopharmaceutical manufacturing ecosystem, announced its launch today.
The company will actively in... |
| 23.11.2020 | Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19 | Resilience, a new biopharmaceutical company backed by $800 million in financing from investors including ARCH Venture Partners and 8VC, has emerged from stealth to transform the way that drugs and therapies are manufactured in the U.S.
Foun... |
| 23.11.2020 | RESILIENCE Launches to Change the Future of Medicine through Manufacturing Innovation | |
| - | Resilience | “Resilience is a biomanufacturing CDMO focused on improving access to complex medicines, with end-to-end solutions for safe and scalable manufacturing.” |
| - | Resilience | “Resilience is a biomanufacturing CDMO improving access to complex medicines, with end-to-end solutions for safe & scalable biologics manufacturing.” |
| - | National Resilience Approved For $410 Million In Financing From The DoD And DFC | National Resilience announced it was approved for $410 million in financing.
National Resilience (Resilience), a technology-focused biomanufacturing company focused on broadening access to complex medicines announced that it has signed a fi... |
| - | Resilience Expands North American Capacity with the Acquisition of Two Premier Biologics Manufacturing Facilities | SAN DIEGO & BOSTON--(BUSINESS WIRE)--Mar 2, 2021--
Resilience (National Resilience, Inc.), a new company building the world’s most advanced biopharmaceutical manufacturing ecosystem, announced it has acquired two premier commercial manu... |
| - | Resilience | “We're changing the way medicine is made - leveraging innovation to better serve scientific discovery, withstand disruptive events, and reach those in need.” |
